Champions Oncology Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Champions Oncology Stock Forecast and Price Target
If the average price target of $6.00 set by distinguished experts for Champions Oncology over the past few weeks is reached this year, there would be a potential upside of approximately 23.2% from the last closing price in May, 2024. This potential increase is based on a high estimate of $6.00 and a low estimate of $6.00. If you are not interested in CSBR stock, you may still be interested in its competitors and their current standings.
23.20% Upside
Champions Oncology Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Champions Oncology's Price has seen an increase, rising from $0.00 to $0.00. This represents a growth of 100.00%. Analysts predict that Champions Oncology's Fair Value will increase in the upcoming year, reaching $5.41. This would represent an increase of 100.00%. Over the next six years, experts predict that Champions Oncology's Fair Value will grow at a rate of 100.00%.
Champions Oncology Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Champions Oncology's Revenue has seen an increase, rising from $32.12M to $53.87M. This represents a growth of 67.71%. Analysts predict that Champions Oncology's Revenue will increase in the upcoming year, reaching $62.23M. This would represent an increase of 15.52%. Over the next six years, experts predict that Champions Oncology's Revenue will grow at a rate of 143.09%.
.jpg)
Champions Oncology EBITDA Forecast for 2023 - 2025 - 2030
Champions Oncology's EBITDA has grown in the last three years, jumping from $-640.00k to $-2.20M – an increase of 243.75%. In the next year, 1 analysts estimate that Champions Oncology's EBITDA will decrease by 28.18%, reaching $-1.58M. For the next six years, the forecast is for EBITDA to grow by 38.86%.
Champions Oncology EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Champions Oncology's EBIT has increased by 202.72%, going from $-1.47M to $-4.45M. According to 2 analysts, Champions Oncology's EBIT will fall by 60.45% in the next year, reaching $-1.76M. Professionals believe that By 2030, Champions Oncology's EBIT will fall to $17.68M – a 497.30% decrease from its current value.
Champions Oncology EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Champions Oncology's EPS has seen an increase, rising from $-0.09 to $0.00. This represents a growth of 100.00%. Analysts predict that Champions Oncology's EPS will increase in the upcoming year, reaching $0.05. This would represent an increase of 100.00%. Over the next six years, experts predict that Champions Oncology's EPS will grow at a rate of 100.00%.
.jpg)